PhD Thesis Proposal: Conner Ubert Skip to main content
All Thayer Events

PhD Thesis Proposal: Conner Ubert

Dec

15

Auditorium H, DHMC/ Online

ZOOM LINK

EPR-Calibrated Oxygen-Enhanced MRI for Absolute pO₂ Mapping in Solid Tumors

Abstract

Tumor hypoxia, a condition of severe oxygen deprivation, is a significant barrier to radiation treatment because hypoxic cells can require up to three times more dose to achieve the same killing effect as well-oxygenated cells. For more than 100 years, hypoxia has been widely recognized as a major contributor to radiation resistance, but clinically translatable methods that report absolute tissue oxygen in a spatially resolved manner have yet to take their rightful place alongside diagnostic information used to inform treatment. Electron paramagnetic resonance (EPR) oximetry offers accurate measurements of the partial pressure of oxygen (pO₂) in tissue but is limited by detector sensitivity, penetration depth, and discrete sampling. Oxygen-enhanced MRI (OE-MRI) can provide whole-tumor coverage but indicates only relative changes in the spin-lattice relaxation rate (R₁) due to oxygen. Bridging modalities that provide accurate but sparse point measurements and spatially rich but relative imaging could support hypoxia-guided RT, as no current method provides spatially resolved maps of tissue pO₂ with the coverage needed to define the hypoxic target volume for RT. This thesis establishes absolute quantitative OE-MRI (qOE-MRI), which uses EPR-measured pO₂ at discrete points as in vivo calibration points to convert relative OE-MRI ∆R₁ maps into spatially resolved pO₂ maps. Building qOE-MRI required three advances, each addressed by one specific aim. Aim 1 developed novel resonators for reliable calibration: a needle-like (OxyTrack) and a flexible EPR sensor that accurately measure pO₂ in deep tissues and body cavities, and a ceramic dielectric MRI coil that provides the B₁ homogeneity required for accurate R₁ mapping. Aim 2 optimized and validated OE-MRI relaxometry so that ∆R₁ is precise and responsive to physiological and therapeutic oxygen changes (i.e., HBO and RT). Aim 3 established that implanted OxyChips with EPR oxygen imaging (EPROI) serve as multi-site pO₂ references that can be measured repeatedly and co-registered with MRI. Aim 4 integrates these components into qOE-MRI, first at high-resolution (9.4T) and then as a high-throughput protocol on a clinical 3T scanner. Since every component (OxyChip implantation, clinical L-band EPR, and 3T OE-MRI) has been used in humans, qOE-MRI offers a translatable route to hypoxia-guided RT intervention.

Thesis Committee

  • Periannan Kuppusamy (chair)
  • Marthony Robins
  • Joseph Weygand
  • Travis Salzillo (UT MD Anderson)